Skip to content

Nuvectis Pharma, Inc. NVCT Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Pfizer logo
PfizerPFE
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
Arcus Biosciences logo
Arcus BiosciencesRCUS
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
Incyte logo
IncyteINCY
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Operating income-$6.3M-12.4%
Net income-$6.1M-13.5%
EPS (diluted)-$0.26+3.7%

Balance sheet

See full
Cash & equivalents$25.1M-15.9%
Total equity$14.2M-32.1%
Total assets$25.4M-15.8%

Cash flow

See full
Operating cash flow-$6.5M-56.0%

Valuation

See full
Market cap$739.27M+335%

Returns & leverage

See full
Return on equity-154.4%+79.4pp
Current ratio2.3×-1.0×

Where this comes from

Reported directly by Nuvectis Pharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvectis Pharma, Inc.'s accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvectis Pharma, Inc.'s accrued manufacturing costs?
Nuvectis Pharma, Inc. (NVCT) reported accrued manufacturing costs of $6.45M in Q1 2026.
How has Nuvectis Pharma, Inc.'s accrued manufacturing costs changed year-over-year?
Nuvectis Pharma, Inc.'s accrued manufacturing costs increased by 28.0% year-over-year, from $5.04M to $6.45M.
What is the long-term trend for Nuvectis Pharma, Inc.'s accrued manufacturing costs?
Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s accrued manufacturing costs has grown at a 164.1% compound annual growth rate (CAGR), from $142K to $6.91M.